Home / Resources / Articles / Issue 180 Item 2 INGAP PHASE 2 TRIALS BEGIN IN 17 CENTERS

Issue 180 Item 2 INGAP PHASE 2 TRIALS BEGIN IN 17 CENTERS

Jun 24, 2004
1,394 views
 

Safety and Efficacy of INGAP-p in Patients with Type 1 & 2 Diabetes. More Information about who qualifies and where the centers are located and how to see if you or your patients might qualify to participate:

As reported earlier in Diabetes In Control in a 3 part series: The Possible Cure. Now that Phase 1 is over and has been successful, phase 2 is now beginning in 17 centers in the US

 

INGAP-p is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients. More Information about who qualifies and where the centers are located and how to see if you or your patients might qualify: CLICK HERE